Product logins

Find logins to all Clarivate products below.

home   •  Research Reports  •  Disease Landscape and Forecast Insights

Renal Cell Carcinoma – Current Treatment – Treatment Sequencing – Renal Cell Carcinoma (US)

Login to access report north_east
Contact sales account_box

Key benefits and uses

Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.

Drill down into physicians’ treatment sequences and understand who to position against or how to defend share.

Identify untapped treatment scenarios and key competitors to aid trial design.

Evaluate unique disease-specific treatment patterns and dynamics to plan and manage sales and marketing resources and execute commercialization messages.

Discover untapped populations to expand product share and drive strategic decisions.

Questions answered

•Where is my product positioned vs. competitors in the treatment journey?
•What are physicians’ most frequent treatment sequences. Who is benefiting and how can I defend my asset’s share and position?
•What are the market-relevant treatment scenarios according to oncology experts?
•Where are the untapped business opportunities that I can capitalize on?
•How can I optimize trial design and ensure a competitive edge for my pipeline asset?

GEOGRAPHY

United States.

PRIMARY MARKET RESEARCH

Survey of 100 U.S. medical oncologists.

Product description

Treatment Sequencing provides disease-specific, sequential treatment patterns in market-relevant treatment scenarios and drug share mapped to treatment journey. The quantitative sequencing analysis illuminates drug positioning through primary market research-based insights from physicians and Clarivate oncology experts’ assumptions.

Table of contents

Contact sales account_box
Login to access report north_east

Related Market Assessment Reports

Report
Obesity / Overweight – Geographic Focus: China – China In-Depth – Obesity / Overweight
Obesity is recognized as a chronic disease and public health crisis globally. The primary goal of treatment is to improve obese patients’ health outcomes and quality of life. Unlike other highly…
north_east
Report
Gastroesophageal Cancer – Geographic Focus: China – China In-Depth – Gastroesophageal cancer
China accounts for nearly half of the cases of gastroesophageal cancer in the world, and its incidence there is expected to increase due to urbanization and an aging population. Current treatment…
north_east
Report
Immunoglobulin A Nephropathy – Access & Reimbursement – Access & Reimbursement – Immunoglobulin A Nephropathy (US)
The U.S. IgA nephropathy (IgAN) therapy market predominantly comprises supportive treatments such as RAAS inhibitors, SGLT-2 inhibitors, immunosuppressants, and/or diuretics. The FDA’s acceptance…
north_east
Report
Heart Failure – Current Treatment – Treatment Algorithms: Claims Data Analysis – Heart Failure with Preserved Ejection Fraction (US)
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all chronic heart failure cases. Even though physicians’ understanding of the disease’s pathophysiology…
north_east
Report
Axial Spondyloarthritis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Ankylosing Spondylitis (US)
Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the sacroiliac joints and the axial skeleton, leading to persistent back pain and stiffness. The main treatment…
north_east

Follow us

Contact us

Sales enquiries north_east
Customer service north_east
Support north_east